Boston Scientific Corporation
Financing
SEC filings to 2026-10-05 · every row opens its filingNewest
No limit
S-3ASR of 2025-02-18. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since. S-3ASR ↗
2 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-03 is not read yet.
Cash
$539.0M
Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗
Raised: 3 of its filings are not read yet.
Also on file: up to $1.00B senior notes agreed 2026-02-26 8-K ↗